Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-07-12 2019-08-17 89158
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-09-04 2019-09-06 92974
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2021-04-09 2021-06-07 137241
APO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Resolved 2023-04-14 2023-05-19 189650
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805

Showing 21 to 28 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1